Cabaletta Bio, Inc. (CABA) › Operating Cash FlowCabaletta Bio, Inc. (CABA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$4.66M2019: -$16.05M2020: -$26.77M2021: -$34.11M2022: -$46.38M2023: -$53.55M2024: -$88.22M2025: -$131.08M-$131.08M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$131.08M-48.6%2024-$88.22M-64.8%2023-$53.55M-15.5%2022-$46.38M-36.0%2021-$34.11M-27.4%2020-$26.77M-66.8%2019-$16.05M-244.2%2018-$4.66M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share